A molecular dynamics investigation on the inhibition mechanism of cholesteryl ester transfer protein by Anacetrapib

被引：0
|
作者：
Mostafa Jamalan
Majid Zeinali
Mohammad Ali Ghaffari
机构：
[1] Ahvaz Jundishapur University of Medical Sciences,Department of Biochemistry
[2] Research Institute of Petroleum Industry,Biotechnology Research Center
来源：
Medicinal Chemistry Research | 2016年 / 25卷
关键词：
Root-mean-square deviation; Inhibitory mechanism; Radius of gyration; Lipoprotein;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：62 / 69
页数：7
相关论文
共 50 条
  • [21] Rationale for cholesteryl ester transfer protein inhibition
    Hewing, Bernd
    Fisher, Edward A.
    CURRENT OPINION IN LIPIDOLOGY, 2012, 23 (04) : 372 - 376
  • [22] Cholesteryl ester transfer protein and its inhibition
    Weber, Olaf
    Bischoff, Hilmar
    Schmeck, Carsten
    Boettcher, Michael-Friedrich
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (18) : 3139 - 3149
  • [23] Is there a need for cholesteryl ester transfer protein inhibition?
    Parini, P
    Rudel, LL
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (03) : 374 - 375
  • [24] Cholesteryl ester transfer protein and its inhibition
    Olaf Weber
    Hilmar Bischoff
    Carsten Schmeck
    Michael-Friedrich Böttcher
    Cellular and Molecular Life Sciences, 2010, 67 : 3139 - 3149
  • [25] Model-Based Development of Anacetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor
    Rajesh Krishna
    Arthur J. Bergman
    Michele Green
    Marissa F. Dockendorf
    John A. Wagner
    Kevin Dykstra
    The AAPS Journal, 2011, 13 : 179 - 190
  • [26] Inhibition of cholesteryl ester transfer protein by anacetrapib does not impair the anti-inflammatory properties of high density lipoprotein
    Han, Seongah
    LeVoci, Lauretta
    Fischer, Paul
    Wang, Sheng-Ping
    Gagen, Karen
    Chen, Ying
    Xie, Dan
    Fisher, Timothy
    Ehrhardt, Anka G.
    Peier, Andrea M.
    Johns, Douglas G.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2013, 1831 (04): : 825 - 833
  • [27] Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with dyslipidemia
    Teramoto, Tamio
    Shirakawa, Masayoshi
    Kikuchi, Masashi
    Nakagomi, Mariko
    Tamura, Satoko
    Surks, Howard K.
    Sisk, Christine McCrary
    Numaguchi, Hirotaka
    ATHEROSCLEROSIS, 2013, 230 (01) : 52 - 60
  • [28] Model-Based Development of Anacetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor
    Krishna, Rajesh
    Bergman, Arthur J.
    Green, Michele
    Dockendorf, Marissa F.
    Wagner, John A.
    Dykstra, Kevin
    AAPS JOURNAL, 2011, 13 (02): : 179 - 190
  • [29] Inhibition of cholesteryl ester transfer protein by apolipoproteins, lipopolysaccharides, and cholesteryl sulfate
    Connolly, DT
    Krul, ES
    Heuvelman, D
    Glenn, KC
    BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1304 (02): : 145 - 160
  • [30] How Anacetrapib Inhibits the Activity of the Cholesteryl Ester Transfer Protein? Perspective through Atomistic Simulations
    Aijanen, Tarja
    Koivuniemi, Artturi
    Javanainenl, Matti
    Rissanen, Sami
    Rog, Tomasz
    Vattulainent, Ilpo
    PLOS COMPUTATIONAL BIOLOGY, 2014, 10 (11)
12345